HER Act
Sponsored By: Representative Brown, Shontel M. [D-OH-11]
Introduced
Summary
Research into endocrine-disrupting chemicals in personal care products and their effects on women's reproductive health. The HER Act directs the Department of Health and Human Services, via the National Institute of Environmental Health Sciences, to fund and oversee studies, publish public reports every 5 years, and support state investigations and awareness campaigns aimed at safer personal care products.
Show full summary
- Women and families: Funds research that aims to identify chemicals and products linked to female reproductive harm and will publish lists of safe and harmful personal care products to guide choices and policy.
- States, territories, and tribes: Authorizes grants for local investigations and public awareness campaigns about alternatives to products that contain endocrine-disrupting chemicals, with grant findings reported publicly and to Congress on a 5-year cycle.
- Regulators and researchers: Requires evidence-based strategies in reports to strengthen the Food and Drug Administration's authority over ingredients judged to harm women's reproductive health and centralizes NIEHS-led research priorities.
Your PRIA Score
Personalized for You
How does this bill affect your finances?
Sign up for a PRIA Policy Scan to see your personalized alignment score for this bill and every other piece of legislation we track. We analyze your financial profile against policy provisions to show you exactly what matters to your wallet.
Bill Overview
Analyzed Economic Effects
2 provisions identified: 2 benefits, 0 costs, 0 mixed.
National research on chemicals harming women
If enacted, HHS, through NIEHS, would fund research on endocrine-disrupting chemicals in personal care products and their effects on the female reproductive system. Within 5 years of enactment, and every 5 years after, HHS would publish a public report. The report would outline findings, note disparities in access to safer products, list products the Secretary finds safe or harmful, and suggest ways to strengthen FDA authority. The bill would also define key terms like endocrine-disrupting chemical, personal care product, Secretary, and which States are covered.
State grants to study harmful products
If enacted, HHS would give grants to States, territories, and Tribes to study how endocrine-disrupting chemicals in personal care products affect women's reproductive health. Grants would also fund public awareness and education on safer product choices. HHS would post a summary of State findings within 5 years of the first awards and every 5 years after.
Sponsors & CoSponsors
Sponsor
Brown, Shontel M. [D-OH-11]
OH • D
Cosponsors
Rep. McIver, LaMonica [D-NJ-10]
NJ • D
Sponsored 6/5/2025
Johnson (GA)
GA • D
Sponsored 6/5/2025
Rep. Pressley, Ayanna [D-MA-7]
MA • D
Sponsored 6/5/2025
Roll Call Votes
No roll call votes available for this bill.
View on Congress.gov